Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-04-14FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for adalimumab-adaz, a biosimilar to adalimumab, confirming its regulatory approval for use.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE [Phase 2]
Phase 2 clinical trial update evaluating PF-06650833, PF-06651600, and tofacitinib alone and in combination in rheumatoid arthritis patients…
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial evaluating the combination of iguratimod with tofacitinib for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Doses of Levilimab When Administered Intravenously and Subcutaneously to Healthy Subjects and Subjects With Active Rheumatoid Arthritis [Phase 3]
Phase 3 two-stage study assessing various doses of levilimab (IV and SC) in healthy subjects and active rheumatoid arthritis patients; curre…
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis [Phase 1]
A Phase 1 study evaluating multiple ascending doses of Rozibusp Alfa (AMG 570) in adults with rheumatoid arthritis has completed and results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-03-31FDA Approved: YUSIMRY — Supplemental Application (Coherus BioSciences Inc)
FDA approved a supplemental Biologics License Application for YUSIMRY (adalimumab-aqvh) by Coherus BioSciences, authorizing the biosimilar p…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial assessing L-carnitine for modulating pain and inflammation in rheumatoid arthritis.
-
FDA approval · 2023-03-30FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxychloroquine sulfate filed by Teva Pharmaceuticals USA, Inc., marking an approved change u…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease [Phase 4]
A Phase 4 clinical trial evaluating combined pneumococcal conjugate and polysaccharide vaccination in adults with inflammatory rheumatic dis…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA [Phase 2]
Phase 2 trial evaluating ATI-450 plus methotrexate versus methotrexate alone in moderate to severe rheumatoid arthritis completed with poste…
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial evaluating the effect of digoxin and ursodeoxycholic acid in patients with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases [Phase 3]
Phase 3 trial update for a COVID-19 vaccine studied in immunosuppressed adults with autoimmune diseases, currently completed.
-
CLINICAL_TRIALS research · 2023-03-09Clinical Trial Update: Meditation Effects on Brain Function in Rheumatoid Arthritis [NA]
A completed clinical trial studying the effects of meditation on brain function in rheumatoid arthritis patients, with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 2]
Phase 2 trial update evaluating KN019 for rheumatoid arthritis with inadequate response to methotrexate, reporting efficacy and safety resul…
-
FDA label_change · 2023-02-28FDA Approved: KEVZARA — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for KEVZARA (sarilumab), resulting in changes to the product label.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System [NA]
A terminated randomized trial update for the Vanguard XP Bicruciate Knee System with posted results, investigating knee arthroplasty outcome…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial evaluating the usability of a subcutaneous auto-injector for CT-P47 in patients with active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis [Phase 2]
Amgen's Phase 2 study evaluating the safety and efficacy of VIB4920 in rheumatoid arthritis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Rheumatoid Arthritis Memory B Cells and Abatacept [Phase 4]
Phase 4 trial evaluating abatacept's impact on memory B cells in rheumatoid arthritis; results were posted on 2023-02-06.
-
FDA approval · 2023-02-03FDA Approved: PIROXICAM — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for piroxicam from Strides Pharma Science Limited. This action completes another regulatory submissi…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study of LY3462817 in Participants With Rheumatoid Arthritis [Phase 2]
Phase 2 trial update for LY3462817 in rheumatoid arthritis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE) [Phase 3]
Phase 3 trial of NI-071 in rheumatoid arthritis completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life
A national observational study assessing the real-world use of Inflectra (infliximab biosimilar) across multiple inflammatory diseases compl…
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update evaluating a COVID-19 vaccine booster in immunocompromised individuals with rheumatic diseases.
-
CLINICAL_TRIALS trial_result · 2022-12-27Clinical Trial Update: Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients [Phase 1, Phase 2]
A clinical trial exploring the effects of moringa leaf extract on disease activity in rheumatoid arthritis patients has completed phases 1 a…